Logo image of RE21.DE

REDEIA CORP SA (RE21.DE) Stock Fundamental Analysis

FRA:RE21 - Deutsche Boerse Ag - ES0173093024 - Common Stock - Currency: EUR

18.29  -0.01 (-0.05%)

Fundamental Rating

4

Overall RE21 gets a fundamental rating of 4 out of 10. We evaluated RE21 against 17 industry peers in the Electric Utilities industry. RE21 has a medium profitability rating, but doesn't score so well on its financial health evaluation. RE21 does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

RE21 had positive earnings in the past year.
RE21 had a positive operating cash flow in the past year.
In the past 5 years RE21 has always been profitable.
RE21 had a positive operating cash flow in each of the past 5 years.
RE21.DE Yearly Net Income VS EBIT VS OCF VS FCFRE21.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

1.2 Ratios

RE21 has a Return On Assets (2.44%) which is in line with its industry peers.
RE21's Return On Equity of 7.15% is on the low side compared to the rest of the industry. RE21 is outperformed by 82.35% of its industry peers.
The Return On Invested Capital of RE21 (4.57%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for RE21 is below the industry average of 8.76%.
Industry RankSector Rank
ROA 2.44%
ROE 7.15%
ROIC 4.57%
ROA(3y)3.9%
ROA(5y)4.28%
ROE(3y)11.26%
ROE(5y)14.12%
ROIC(3y)5.4%
ROIC(5y)6%
RE21.DE Yearly ROA, ROE, ROICRE21.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of RE21 (23.11%) is better than 94.12% of its industry peers.
In the last couple of years the Profit Margin of RE21 has declined.
Looking at the Operating Margin, with a value of 44.44%, RE21 belongs to the top of the industry, outperforming 94.12% of the companies in the same industry.
RE21's Operating Margin has declined in the last couple of years.
RE21 has a better Gross Margin (102.40%) than 100.00% of its industry peers.
In the last couple of years the Gross Margin of RE21 has remained more or less at the same level.
Industry RankSector Rank
OM 44.44%
PM (TTM) 23.11%
GM 102.4%
OM growth 3Y-3.37%
OM growth 5Y-3.68%
PM growth 3Y-12.8%
PM growth 5Y-8.28%
GM growth 3Y0.16%
GM growth 5Y0.22%
RE21.DE Yearly Profit, Operating, Gross MarginsRE21.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

3

2. Health

2.1 Basic Checks

RE21 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for RE21 remains at a similar level compared to 1 year ago.
RE21 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, RE21 has a worse debt to assets ratio.
RE21.DE Yearly Shares OutstandingRE21.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
RE21.DE Yearly Total Debt VS Total AssetsRE21.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

RE21 has an Altman-Z score of 1.32. This is a bad value and indicates that RE21 is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.32, RE21 perfoms like the industry average, outperforming 47.06% of the companies in the same industry.
RE21 has a Debt/Equity ratio of 1.00. This is a neutral value indicating RE21 is somewhat dependend on debt financing.
RE21's Debt to Equity ratio of 1.00 is fine compared to the rest of the industry. RE21 outperforms 76.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z 1.32
ROIC/WACC0.84
WACC5.46%
RE21.DE Yearly LT Debt VS Equity VS FCFRE21.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.18 indicates that RE21 should not have too much problems paying its short term obligations.
RE21's Current ratio of 1.18 is amongst the best of the industry. RE21 outperforms 82.35% of its industry peers.
RE21 has a Quick Ratio of 1.14. This is a normal value and indicates that RE21 is financially healthy and should not expect problems in meeting its short term obligations.
RE21's Quick ratio of 1.14 is fine compared to the rest of the industry. RE21 outperforms 76.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.14
RE21.DE Yearly Current Assets VS Current LiabilitesRE21.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

3

3. Growth

3.1 Past

RE21 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.00%.
The earnings per share for RE21 have been decreasing by -14.24% on average. This is quite bad
Looking at the last year, RE21 shows a very negative growth in Revenue. The Revenue has decreased by -22.96% in the last year.
Measured over the past years, RE21 shows a decrease in Revenue. The Revenue has been decreasing by -4.50% on average per year.
EPS 1Y (TTM)-42%
EPS 3Y-21.18%
EPS 5Y-14.24%
EPS Q2Q%23.81%
Revenue 1Y (TTM)-22.96%
Revenue growth 3Y-6.54%
Revenue growth 5Y-4.5%
Sales Q2Q%-11.24%

3.2 Future

The Earnings Per Share is expected to grow by 16.26% on average over the next years. This is quite good.
RE21 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.54% yearly.
EPS Next Y54.79%
EPS Next 2Y35.97%
EPS Next 3Y24.74%
EPS Next 5Y16.26%
Revenue Next Year-5.5%
Revenue Next 2Y1.78%
Revenue Next 3Y3.01%
Revenue Next 5Y3.54%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
RE21.DE Yearly Revenue VS EstimatesRE21.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B 2B
RE21.DE Yearly EPS VS EstimatesRE21.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 27.30, which means the current valuation is very expensive for RE21.
Based on the Price/Earnings ratio, RE21 is valued a bit more expensive than the industry average as 76.47% of the companies are valued more cheaply.
RE21's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.45.
Based on the Price/Forward Earnings ratio of 16.03, the valuation of RE21 can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of RE21 indicates a somewhat cheap valuation: RE21 is cheaper than 64.71% of the companies listed in the same industry.
RE21 is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 27.3
Fwd PE 16.03
RE21.DE Price Earnings VS Forward Price EarningsRE21.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

64.71% of the companies in the same industry are cheaper than RE21, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.12
RE21.DE Per share dataRE21.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as RE21's earnings are expected to grow with 24.74% in the coming years.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y35.97%
EPS Next 3Y24.74%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.55%, RE21 has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 4.19, RE21 has a dividend in line with its industry peers.
RE21's Dividend Yield is a higher than the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 3.55%

5.2 History

The dividend of RE21 has a limited annual growth rate of 1.50%.
Dividend Growth(5Y)1.5%
Div Incr Years1
Div Non Decr Years3
RE21.DE Yearly Dividends per shareRE21.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

RE21 pays out 155.39% of its income as dividend. This is not a sustainable payout ratio.
The dividend of RE21 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP155.39%
EPS Next 2Y35.97%
EPS Next 3Y24.74%
RE21.DE Yearly Income VS Free CF VS DividendRE21.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B
RE21.DE Dividend Payout.RE21.DE Dividend Payout, showing the Payout Ratio.RE21.DE Dividend Payout.PayoutRetained Earnings

REDEIA CORP SA

FRA:RE21 (7/3/2025, 7:00:00 PM)

18.29

-0.01 (-0.05%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryElectric Utilities
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-30 2025-07-30
Inst Owners31.96%
Inst Owner ChangeN/A
Ins Owners5%
Ins Owner ChangeN/A
Market Cap9.90B
Analysts72
Price Target19.71 (7.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.55%
Yearly Dividend1.06
Dividend Growth(5Y)1.5%
DP155.39%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-76.82%
Min EPS beat(2)-147.36%
Max EPS beat(2)-6.28%
EPS beat(4)0
Avg EPS beat(4)-48.85%
Min EPS beat(4)-147.36%
Max EPS beat(4)-6.28%
EPS beat(8)2
Avg EPS beat(8)-22.4%
EPS beat(12)5
Avg EPS beat(12)-15.43%
EPS beat(16)8
Avg EPS beat(16)-11.7%
Revenue beat(2)0
Avg Revenue beat(2)-24.23%
Min Revenue beat(2)-45.83%
Max Revenue beat(2)-2.63%
Revenue beat(4)0
Avg Revenue beat(4)-14.78%
Min Revenue beat(4)-45.83%
Max Revenue beat(4)-2.63%
Revenue beat(8)1
Avg Revenue beat(8)-5.1%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.17%
PT rev (3m)2.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.94%
EPS NY rev (1m)0%
EPS NY rev (3m)0.86%
Revenue NQ rev (1m)-8.5%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.45%
Valuation
Industry RankSector Rank
PE 27.3
Fwd PE 16.03
P/S 6.21
P/FCF N/A
P/OCF 10.36
P/B 1.92
P/tB 2.12
EV/EBITDA 13.12
EPS(TTM)0.67
EY3.66%
EPS(NY)1.14
Fwd EY6.24%
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)1.77
OCFY9.66%
SpS2.95
BVpS9.53
TBVpS8.62
PEG (NY)0.5
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.44%
ROE 7.15%
ROCE 5.86%
ROIC 4.57%
ROICexc 4.95%
ROICexgc 5.18%
OM 44.44%
PM (TTM) 23.11%
GM 102.4%
FCFM N/A
ROA(3y)3.9%
ROA(5y)4.28%
ROE(3y)11.26%
ROE(5y)14.12%
ROIC(3y)5.4%
ROIC(5y)6%
ROICexc(3y)5.94%
ROICexc(5y)6.62%
ROICexgc(3y)6.37%
ROICexgc(5y)7.12%
ROCE(3y)6.92%
ROCE(5y)7.7%
ROICexcg growth 3Y-15.65%
ROICexcg growth 5Y-10.59%
ROICexc growth 3Y-14.67%
ROICexc growth 5Y-10.02%
OM growth 3Y-3.37%
OM growth 5Y-3.68%
PM growth 3Y-12.8%
PM growth 5Y-8.28%
GM growth 3Y0.16%
GM growth 5Y0.22%
F-Score6
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Debt/EBITDA 4.39
Cap/Depr 233.63%
Cap/Sales 67.66%
Interest Coverage 5.71
Cash Conversion 81.66%
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 1.14
Altman-Z 1.32
F-Score6
WACC5.46%
ROIC/WACC0.84
Cap/Depr(3y)169.97%
Cap/Depr(5y)143.18%
Cap/Sales(3y)48.95%
Cap/Sales(5y)40.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42%
EPS 3Y-21.18%
EPS 5Y-14.24%
EPS Q2Q%23.81%
EPS Next Y54.79%
EPS Next 2Y35.97%
EPS Next 3Y24.74%
EPS Next 5Y16.26%
Revenue 1Y (TTM)-22.96%
Revenue growth 3Y-6.54%
Revenue growth 5Y-4.5%
Sales Q2Q%-11.24%
Revenue Next Year-5.5%
Revenue Next 2Y1.78%
Revenue Next 3Y3.01%
Revenue Next 5Y3.54%
EBIT growth 1Y-23.31%
EBIT growth 3Y-9.69%
EBIT growth 5Y-8.02%
EBIT Next Year64.03%
EBIT Next 3Y25.42%
EBIT Next 5Y16.78%
FCF growth 1Y73.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y94.27%
OCF growth 3Y-15.88%
OCF growth 5Y-1.78%